January 05, 2010 10:04 ET

CEO of Cord Blood America (OTCBB: CBAI) Reveals His Company Has Voracious Appetite for Growth, Expansion and Acquisitions

LOS ANGELES, CA--(Marketwire - January 5, 2010) - BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has an exclusive interview with Matthew L. Schissler, the CEO of Cord Blood America (OTCBB: CBAI), the small cap company that is preparing to open its seventeen thousand square foot state-of-the-art stem cell storage facility and laboratory in Las Vegas.

In the interview, the CEO reveals that his company is focused on three core goals for 2010.

"One of those three core goals is the diversification of revenue streams," says Schissler. "Not only will we have our own organic growth engine by processing and storing for our own company, but (yesterday) we announced that we have entered into a letter of agreement to process and store for another very successful stem cell company.

"That's going to be the flavor for 2010 and onward -- diversification of revenue streams by using our new facility to its full capacity. The other goal is continued growth and we're going to be very focused on acquisitions.

"In fact, I'll tell you that in 2010 we have a voracious appetite for acquisitions. With the economy the way it is, a lot of stem cell companies are struggling and we've been very fortunate to have our company go in the right direction by reducing debt and raising capital. We feel it's a very good time for us to make some acquisitions and so we're going to be very focused on that this year."

The interview is available now at BioMedReports.Com:

Biotech investors interested in accessing the news portal's complete database of clinical trials and upcoming FDA decisions can access that information here:

About BioMedReports.Com is a news portal covering the biomedical news and financial sector. BioMedReports is not paid or compensated to report the news and developments of publicly traded companies.

For more biomedical sector and investment news go to

Contact Information

  • Media Contacts Only:
    Mary Davila
    Assistant Editor, BioMedReports.Com
    e-mail: Email Contact
    Tel: +1 323 472 4480
    Fax: +1 888 210 3556